Literature DB >> 18216063

Changes in elastic fibres in the small airways and alveoli in COPD.

P N Black1, P S T Ching, B Beaumont, S Ranasinghe, G Taylor, M J Merrilees.   

Abstract

Small airways are the major site of airflow obstruction in chronic obstructive pulmonary disease (COPD). This is attributed to loss of elastin in alveoli and fibrosis in small airways. In the present study, it was hypothesised that changes to elastic fibres in alveoli might be paralleled by a similar reduction in elastic fibres in small airways. Tissue blocks from patients who had lobectomy for bronchial carcinoma were studied. Patients were classified as COPD (forced expiratory volume in one second (FEV(1)) < 80% predicted, FEV(1)/forced vital capacity (FVC) < 0.7) or controls (FEV(1) > or = 80% pred, FEV(1)/FVC > or = 0.7). Elastic fibres were visualised using Elastic van Gieson staining and the volume fraction (v/f) of elastic fibres was determined as a percentage of tissue volume using point counting. Elastic fibre networks were also visualised by confocal microscopy. The v/f for elastic fibres in alveoli was 18.6% for COPD and 32.8% in controls. In the airways the v/f was 14.6% for COPD and 25.5% in controls. FEV(1)% predicted was correlated with v/f in both alveoli and small airways. The volume fraction of elastic fibres was reduced to a similar extent in small airways and alveoli in chronic obstructive pulmonary disease and both were correlated with the extent of airflow obstruction. Loss of elastic fibres in small airways may contribute to the development of airflow obstruction in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  2008        PMID: 18216063     DOI: 10.1183/09031936.00017207

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  44 in total

1.  Insulin modulates inflammatory and repair responses to elastase-induced emphysema in diabetic rats.

Authors:  Antonio Di Petta; Karin V Greco; Eveline O Castro; Fernanda D T Q S Lopes; Milton A Martins; Vera L Capelozzi; Luiz F P Moreira; Paulina Sannomiya
Journal:  Int J Exp Pathol       Date:  2011-09-22       Impact factor: 1.925

2.  Serum cystatin C as a potential biomarker for the evaluation COPD.

Authors:  Yonghong Zhang; Yanting Zhu; Yuanyuan Wu; Guizuo Wang; Xinming Xie; Rui Ke; Shaojun Li; Lu Liu; Wei Fen; Fengjuan Li; Fangxia Li; Manxiang Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Targeted drug delivery to emphysematous lungs: Inhibition of MMPs by doxycycline loaded nanoparticles.

Authors:  Vaideesh Parasaram; Nasim Nosoudi; Renee J LeClair; Andrew Binks; Naren Vyavahare
Journal:  Pulm Pharmacol Ther       Date:  2016-06-25       Impact factor: 3.410

4.  IUGR decreases elastin mRNA expression in the developing rat lung and alters elastin content and lung compliance in the mature rat lung.

Authors:  Lisa A Joss-Moore; Yan Wang; Xing Yu; Michael S Campbell; Christopher W Callaway; Robert A McKnight; Albert Wint; Mar Janna Dahl; Randal O Dull; Kurt H Albertine; Robert H Lane
Journal:  Physiol Genomics       Date:  2011-03-01       Impact factor: 3.107

5.  Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation.

Authors:  Mervyn J Merrilees; Brent W Beaumont; Kathleen R Braun; Anita C Thomas; Inkyung Kang; Aleksander Hinek; Alberto Passi; Thomas N Wight
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

Review 6.  Extracellular matrix in lung development, homeostasis and disease.

Authors:  Yong Zhou; Jeffrey C Horowitz; Alexandra Naba; Namasivayam Ambalavanan; Kamran Atabai; Jenna Balestrini; Peter B Bitterman; Richard A Corley; Bi-Sen Ding; Adam J Engler; Kirk C Hansen; James S Hagood; Farrah Kheradmand; Qing S Lin; Enid Neptune; Laura Niklason; Luis A Ortiz; William C Parks; Daniel J Tschumperlin; Eric S White; Harold A Chapman; Victor J Thannickal
Journal:  Matrix Biol       Date:  2018-03-08       Impact factor: 11.583

7.  Prolidase activity dysregulation and its correlation with oxidative-antioxidative status in chronic obstructive pulmonary disease.

Authors:  Mehmet Gencer; Nurten Aksoy; E Canan Dagli; Elmas Uzer; Sahin Aksoy; Sahbettin Selek; Hakim Celik; Hale Cakir
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

8.  Pentagalloyl glucose increases elastin deposition, decreases reactive oxygen species and matrix metalloproteinase activity in pulmonary fibroblasts under inflammatory conditions.

Authors:  Vaideesh Parasaram; Nasim Nosoudi; Aniqa Chowdhury; Naren Vyavahare
Journal:  Biochem Biophys Res Commun       Date:  2018-03-19       Impact factor: 3.575

9.  Elastin expression in very severe human COPD.

Authors:  G Deslee; J C Woods; C M Moore; L Liu; S H Conradi; M Milne; D S Gierada; J Pierce; A Patterson; R A Lewit; J T Battaile; M J Holtzman; J C Hogg; R A Pierce
Journal:  Eur Respir J       Date:  2009-04-08       Impact factor: 16.671

10.  Tropoelastin modulates TGF-β1-induced expression of VEGF and CTGF in airway smooth muscle cells.

Authors:  Caroline J Reddel; Daniele Cultrone; Jelena Rnjak-Kovacina; Anthony S Weiss; Janette K Burgess
Journal:  Matrix Biol       Date:  2013-04-15       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.